Nanotechnology and nanomedicine: Going small means aiming big

Mahesh Kumar Teli, Srinivas Mutalik, G. K. Rajanikant

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Nanotechnology is an emerging branch of science for designing tools and devices of size 1 to 100 nm with specific function at the cellular, atomic and molecular levels. The concept of employing nanotechnology in biomedical research and clinical practice is best known as nanomedicine. Nanomedicine is an upcoming field that could potentially make a major impact to human health. Nanomaterials are increasingly used in diagnostics, imaging and targeted drug delivery. Nanotechnology will assist the integration of diagnostics/imaging with therapeutics and facilitates the development of personalized medicine, i.e. prescription of specific medications best suited for an individual. This review provides an integrated overview of application of nanotechnology based molecular diagnostics and drug delivery in the development of nanomedicine and ultimately personalized medicine. Finally, we identify critical gaps in our knowledge of nanoparticle toxicity and how these gaps need to be evaluated to enable nanotechnology to transit safely from bench to bedside.

Original languageEnglish
Pages (from-to)1882-1892
Number of pages11
JournalCurrent Pharmaceutical Design
Volume16
Issue number16
DOIs
Publication statusPublished - 2010

Fingerprint

Nanomedicine
Nanotechnology
Precision Medicine
Diagnostic Imaging
Molecular Pathology
Nanostructures
Practice Guidelines
Pharmaceutical Preparations
Nanoparticles
Prescriptions
Biomedical Research
Equipment and Supplies
Health

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this

Teli, Mahesh Kumar ; Mutalik, Srinivas ; Rajanikant, G. K. / Nanotechnology and nanomedicine : Going small means aiming big. In: Current Pharmaceutical Design. 2010 ; Vol. 16, No. 16. pp. 1882-1892.
@article{f53efaad9cab418a9339872b1a30edd9,
title = "Nanotechnology and nanomedicine: Going small means aiming big",
abstract = "Nanotechnology is an emerging branch of science for designing tools and devices of size 1 to 100 nm with specific function at the cellular, atomic and molecular levels. The concept of employing nanotechnology in biomedical research and clinical practice is best known as nanomedicine. Nanomedicine is an upcoming field that could potentially make a major impact to human health. Nanomaterials are increasingly used in diagnostics, imaging and targeted drug delivery. Nanotechnology will assist the integration of diagnostics/imaging with therapeutics and facilitates the development of personalized medicine, i.e. prescription of specific medications best suited for an individual. This review provides an integrated overview of application of nanotechnology based molecular diagnostics and drug delivery in the development of nanomedicine and ultimately personalized medicine. Finally, we identify critical gaps in our knowledge of nanoparticle toxicity and how these gaps need to be evaluated to enable nanotechnology to transit safely from bench to bedside.",
author = "Teli, {Mahesh Kumar} and Srinivas Mutalik and Rajanikant, {G. K.}",
year = "2010",
doi = "10.2174/138161210791208992",
language = "English",
volume = "16",
pages = "1882--1892",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "16",

}

Nanotechnology and nanomedicine : Going small means aiming big. / Teli, Mahesh Kumar; Mutalik, Srinivas; Rajanikant, G. K.

In: Current Pharmaceutical Design, Vol. 16, No. 16, 2010, p. 1882-1892.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nanotechnology and nanomedicine

T2 - Going small means aiming big

AU - Teli, Mahesh Kumar

AU - Mutalik, Srinivas

AU - Rajanikant, G. K.

PY - 2010

Y1 - 2010

N2 - Nanotechnology is an emerging branch of science for designing tools and devices of size 1 to 100 nm with specific function at the cellular, atomic and molecular levels. The concept of employing nanotechnology in biomedical research and clinical practice is best known as nanomedicine. Nanomedicine is an upcoming field that could potentially make a major impact to human health. Nanomaterials are increasingly used in diagnostics, imaging and targeted drug delivery. Nanotechnology will assist the integration of diagnostics/imaging with therapeutics and facilitates the development of personalized medicine, i.e. prescription of specific medications best suited for an individual. This review provides an integrated overview of application of nanotechnology based molecular diagnostics and drug delivery in the development of nanomedicine and ultimately personalized medicine. Finally, we identify critical gaps in our knowledge of nanoparticle toxicity and how these gaps need to be evaluated to enable nanotechnology to transit safely from bench to bedside.

AB - Nanotechnology is an emerging branch of science for designing tools and devices of size 1 to 100 nm with specific function at the cellular, atomic and molecular levels. The concept of employing nanotechnology in biomedical research and clinical practice is best known as nanomedicine. Nanomedicine is an upcoming field that could potentially make a major impact to human health. Nanomaterials are increasingly used in diagnostics, imaging and targeted drug delivery. Nanotechnology will assist the integration of diagnostics/imaging with therapeutics and facilitates the development of personalized medicine, i.e. prescription of specific medications best suited for an individual. This review provides an integrated overview of application of nanotechnology based molecular diagnostics and drug delivery in the development of nanomedicine and ultimately personalized medicine. Finally, we identify critical gaps in our knowledge of nanoparticle toxicity and how these gaps need to be evaluated to enable nanotechnology to transit safely from bench to bedside.

UR - http://www.scopus.com/inward/record.url?scp=77953525110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953525110&partnerID=8YFLogxK

U2 - 10.2174/138161210791208992

DO - 10.2174/138161210791208992

M3 - Article

C2 - 20222866

AN - SCOPUS:77953525110

VL - 16

SP - 1882

EP - 1892

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 16

ER -